id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-22 00:58:59
expired found date
-
created at
2024-06-04 05:48:00
updated at
2026-01-10 10:14:01
length
11
crc
17529
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
71042
mp size raw text
5375
mp inner links count
1
mp inner links status
20 (imported)
title
Home
description
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.
image
site name
Heron Therapeutics
author
updated
2025-12-15 06:31:18
raw text
Acute Care and Oncology Care Solutions | Heron Therapeutics Skip to content Mar 12 2024 - Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results... Feb 28 2024 - Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results... Jan 24 2024 - Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion... Jan 7 2024 - Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand... × Product Portfolio Overview Product Pipeline SUSTOL® CINVANTI® ZYNRELEF® APONVIE™ Our Focus Overview Acute Care Oncology Care Medical Professionals Overview Acute Care Solutions Oncology Care Solutions Publications Scientific Posters and Presentations IITs, Grants, Sponsorships, and Contributions Investors Corporate Presentations News Releases Events SEC Filings Stock Information Analyst Coverage Corporate Governance Board of Di...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
4213
text words
733
text unique words
360
text lines
136
text sentences
29
text paragraphs
8
text words per sentence
25
text matched phrases
12
text matched dictionaries
3
links self subdomains
0
links other subdomains
23 - ir.herontx.com
links other domains
2 - zynrelef.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
1 - linkedin.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-15 06:31:18
rss path
rss status
32 (unknown)
rss found date
2024-04-07 00:02:25
rss size orig
576
rss items
0
rss spam phrases
0
rss detected language
126 (language undetectable (empty document, too short, or engines disagree))
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
31
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-30 11:22:58
sitemap process date
2025-05-04 07:26:25
sitemap first import date
-
sitemap last import date
2026-01-10 10:14:01